[3623] Yamada, K., Holth J. K., Liao F., Stewart F. R., Mahan T. E., Jiang H., et al. (2014).  Neuronal activity regulates extracellular tau in vivo. The Journal of Experimental Medicine. 211(3), 387 - 393.

[3410] Verghese, P. B., Castellano J. M., Garai K., Wang Y., Jiang H., Shah A., et al. (2013).  ApoE influences amyloid-β (Aβ) clearance despite minimal apoE/Aβ association in physiological conditions. Proceedings of the National Academy of Sciences. 110(19), E1807 - E1816.

[3594] Musiek, E. S., Lim M. M., Yang G., Bauer A. Q., Qi L., Lee Y., et al. (2013).  Circadian clock proteins regulate neuronal redox homeostasis and neurodegeneration. Journal of Clinical Investigation. 123(12), 5389 - 5400.

[3614] Vos, S JB., Xiong C., Visser P J., Jasielec M. S., Hassenstab J., Grant E. A., et al. (2013).  Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study. The Lancet Neurology. 12(10), 957 - 965.

[3126] Esparza, T. J., Zhao H., Cirrito J. R., Cairns N. J., Bateman R. J., Holtzman D. M., et al. (2012).  Amyloid-beta oligomerization in alzheimer dementia vs. high pathology controls. Annals of Neurology. n/a - n/a.

[2925] Bell, R. D., Winkler E. A., Singh I., Sagare A. P., Deane R., Wu Z., et al. (2012).  Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature.

[2997] Bateman, R. J., Xiong C., Benzinger T. L. S., Fagan A. M., Goate A., Fox N. C., et al. (2012).  Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease. New England Journal of Medicine. 120723122607004 - 120723122607004.

[3092] Roh, J H., Huang Y., Bero A. W., Kasten T., Stewart F. R., Bateman R. J., et al. (2012).  Disruption of the Sleep-Wake Cycle and Diurnal Fluctuation of β-Amyloid in Mice with Alzheimer’s Disease Pathology. Science Translational Medicine. 4(150), 150ra122 - 150ra122.

[2785] Kauwe, J. S. K., Cruchaga C., Karch C. M., Sadler B., Lee M., Mayo K., et al. (2011).  Fine Mapping of Genetic Variants in BIN1, CLU, CR1 and PICALM for Association with Cerebrospinal Fluid Biomarkers for Alzheimer's Disease. PLoS ONE. 6(2), e15918 - e15918.

[1888] Galvin, J. E., Fagan A. M., Holtzman D. M., Mintun M. A., & Morris J. C. (2010).  Relationship of dementia screening tests with biomarkers of Alzheimer’s disease. Brain. 133(11), 3290 - 3300.